Completed NA INTERVENTIONAL 1-arm NCT01425957

Identification of Biomarkers Sensitive to Disease Progression in Patients With Mild Cognitive Impairment

Identification of Biomarkers Sensitive to Disease Progression in Patients With Mild Cognitive Impairment: a Two-part Clinical Study. PartA: Multisite MRI Acquisition, Protocol Harmonization. PartB: Identification of Biomarkers Sensitive to Disease Progression in Patients With Mild Cognitive Impairment: a Clinical Study

Sponsor: European Union

Conditions MILD COGNITIVE IMPAIRMENT

Interventions Lumbar puncture

Updated 5 times since 2017 Last updated: Oct 30, 2015 Started: Dec 31, 2011 Primary completion: Aug 31, 2015 Completion: Oct 31, 2015

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This NA trial investigates MILD COGNITIVE IMPAIRMENT and is currently completed. European Union leads this study, which shows 5 recorded versions since 2011 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Jan 2021 — Jul 2024 [monthly]

Completed NA
Jun 2018 — Jan 2021 [monthly]

Completed NA
Jan 2017 — Jun 2018 [monthly]

Completed NA

First recorded

Dec 2011

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

European Union
Qualissima

Data source: Qualissima

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

Amsterdam, Netherlands , Barcelona, Spain , Brescia, Italy , Essen, Germany , Genoa, Italy , Leipzig, Germany , Lille, France , Marseille, France , Napoli, Italy , Perugia, Italy and 3 more locations